Brought to you by 
Horizon Therapeutics raises $600mm through senior note sale
08 Aug 2019
Executive Summary
Horizon Therapeutics PLC (formerly Horizon Pharma PLC; rare and rheumatic diseases) completed a private placement, issuing Citigroup Global Markets and other institutional buyers $600mm aggregate principal amount of 5.5% senior notes due 2027. The company will use the proceeds, as well as about $65mm of its cash on hand, to redeem or prepay $625mm of its outstanding debt (including associated premiums, fees, and accrued interest) from existing term loans and credit facilities.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Nonconvertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Horizon Therapeutics raises $600mm through senior note sale
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice